GPC3 and hepatocellular carcinoma: At 10 μg/mL, all BsAbs bound specifically to GPC3+ HCC lines, G1 cells, and CD16A+ NK cells (comprising ~15% of PBMCs), but not to GPC3-/CD16A- A431 cells (Figure 2D).